ENA-78


Also found in: Medical.
AcronymDefinition
ENA-78Epithelial Cell-Derived Neutrophil-Activating Peptide 78
References in periodicals archive ?
Zineh, "Modulatory effect of fenofibrate on endothelial production of neutrophil chemokines IL-8 and ENA-78," Cardiovascular Drugs and Therapy, vol.
(a) Four chemokines (ENA-78, GRO, IL-8, and MCP-1) with obvious enhanced brightness after being incubated with IL-34 (right part) for 72h were picked out for further analysis.
Schnyder-Candrian, "Regulation and function of the CXC chemokine ENA-78 in monocytes and its role in disease," Journal of Leukocyte Biology, vol.
Strieter, "Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8," The Journal of Experimental Medicine, vol.
For the chemokines a one-way ANOVA test confirmed a significant variation between the mRNA concentrations of the ectopic endometriotic tissue with eutopic endometrial tissue for ENA-78 (P = 0.0039) and RANTES (P = 0.0490), but not for MCP-1 (P = 0.1251) or IL-8 (P = 0.7991) (Figure 1).
MCP-1 expression in the RVS (1.700 [+ or -] 0.576, n = 5) was not significantly higher than either the ovarian (1.393 [+ or -] 0.632, n = 25) or the peritoneal samples (0.814 [+ or -] 0.215, n = 13), which was also the case for ENA-78 (Peritoneal; 1.497 [+ or -] 0.465, n = 13, ovarian; 2.988 [+ or -] 1.429, n = 25, RVS; 4.822 [+ or -] 2.969, n = 5), IL-8 (peritoneum; 1.548 [+ or -] 1.188, n = 13, ovaries; 1.352 [+ or -] 0.471, n = 25, RVS; 2.017 [+ or -] 0.543, n = 6), and RANTES (peritoneal; 0.288 [+ or -] 0.064, n = 11, ovarian; 0.364 [+ or -] 0.054, n = 22, RVS; 0.528 [+ or -] 0.222, n = 6) (Figure 3).